I am currently pursuing a PhD in population health (October 2015 – present), funded by the Perros Trust, at the Bristol Medical School, University of Bristol, UK. My project investigates whether commonly prescribed drugs can be repurposed for the treatment of Alzheimer’s and other neurodegenerative diseases, using data from the Clinical Practice Research Datalink (CPRD). In 2017, I took a six-month secondment to work at GlaxoSmithKline (GSK), funded by the Elizabeth Blackwell Institute Proximity to Discovery Award. During my time at GSK, I investigated the use of genetic evidence in target validation. Prior to my PhD, I completed an MMath degree in Mathematics at the University of Leicester, UK with a year abroad at the University at Buffalo, USA. My research interests include pharmacoepidemiology and instrumental variable analysis.